Acadia Pharmaceuticals (0A4W.LSE) Q4 2024 Earnings

Nov 6Confirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
0.05
0.13
0.21
0.29

Details

Expected EPS
0.13808
Actual EPS
0.2
Surprise EPS
0.06
Surprise Percent
+44.84%

Description

⁨Acadia Pharmaceuticals⁩ (⁦0A4W.LSE⁩) has reported earnings of ⁦0.2⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts